Downregulation of the coxsackie and adenovirus receptor in cancer cells by hypoxia depends on HIF-1α

被引:23
|
作者
Kuester, K. [2 ,3 ]
Koschel, A. [2 ,3 ]
Rohwer, N. [2 ,3 ]
Fischer, A. [2 ,3 ]
Wiedenmann, B. [2 ,3 ]
Anders, M. [1 ]
机构
[1] Univ Hosp Hamburg Eppendorf, Dept Interdisciplinary Endoscopy, D-20246 Hamburg, Germany
[2] Charite, Dept Internal Med, Div Gastroenterol, Berlin, Germany
[3] Charite, Dept Internal Med, Div Hepatol, Berlin, Germany
关键词
coxsackie adenovirus receptor; hypoxia; HIF-1; alpha; BLADDER-CANCER; GENE-THERAPY; TIGHT JUNCTION; EXPRESSION; CAR; PROTEIN; GROWTH; DOMAIN; REPLICATION; CARCINOMA;
D O I
10.1038/cgt.2009.49
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Loss of the coxsackie and adenovirus receptor (CAR) has been found in various human cancers. Underlying mechanisms, however, are still poorly understood. Therefore, the objective of this study was to investigate the function of hypoxia, a ubiquitous phenomenon in carcinomas, in CAR regulation. In our approach, hypoxia and treatment with cobalt-(II)-chloride (CoCl2) induced a downregulation of CAR protein and mRNA expression, as well as a suppression of CAR gene promoter activity in AGS (gastric), SW480 (colon) and PC3 (prostate) cancer cells. In line with these findings we noted a decreased adenoviral uptake under hypoxic conditions. Aiming to further elucidate the molecular basis of this observation, a full-length hypoxia-inducible factor-1 alpha (HIF-1 alpha) cDNA was ectopically overexpressed in the AGS cell line diminishing CAR expression and CAR gene promoter activity. In line with these findings, exposure of HIF-1 alpha-deficient AGS cells to hypoxia did not alter CAR mRNA expression level. On the basis of these data, it may be suggested that loss of CAR in human cancer cell lines under hypoxic conditions occurs in an HIF-1 alpha-dependent manner. Cancer Gene Therapy (2010) 17, 141-146; doi:10.1038/cgt.2009.49; published on line 10 July 2009
引用
收藏
页码:141 / 146
页数:6
相关论文
共 50 条
  • [1] Downregulation of the coxsackie and adenovirus receptor in cancer cells by hypoxia depends on HIF-1α
    K Küster
    A Koschel
    N Rohwer
    A Fischer
    B Wiedenmann
    M Anders
    Cancer Gene Therapy, 2010, 17 : 141 - 146
  • [2] Hypoxia, HIF-1, and cancer
    Semenza, G. L.
    CLINICAL & EXPERIMENTAL METASTASIS, 2008, 25 : 20 - 20
  • [3] HIF-1 at the crossroads of hypoxia, inflammation, and cancer
    Balamurugan, Kuppusamy
    INTERNATIONAL JOURNAL OF CANCER, 2016, 138 (05) : 1058 - 1066
  • [4] Inflammation, but not hypoxia, mediated HIF-1α activation depends on COX-2
    Stasinopoulos, Ioannis
    O'Brien, David R.
    Bhujwalla, Zaver M.
    CANCER BIOLOGY & THERAPY, 2009, 8 (01) : 31 - 35
  • [5] Enhanced overexpression of an HIF-1/hypoxia-related protein in cancer cells
    Cangul, H
    Salnikow, K
    Yee, H
    Zagzag, D
    Commes, T
    Costa, M
    ENVIRONMENTAL HEALTH PERSPECTIVES, 2002, 110 : 783 - 788
  • [6] Hypoxia-induced chemoresistance in cancer cells: The role of not only HIF-1
    Doktorova, Helena
    Hrabeta, Jan
    Khalil, Mohamed Ashraf
    Eckschlager, Tomas
    BIOMEDICAL PAPERS-OLOMOUC, 2015, 159 (02): : 166 - 177
  • [7] The number of regulatory T cells in prostate cancer is associated with the androgen receptor and hypoxia-inducible factor (HIF)-2α but not HIF-1α
    Fox, Stephen B.
    Launchbury, Rosalind
    Bates, Gaynor J.
    Han, Cheng
    Shaida, Nadeem
    Malone, Peter R.
    Harris, Adrian L.
    Banham, Alison H.
    PROSTATE, 2007, 67 (06): : 623 - 629
  • [8] Hypoxia and HIF-1α in chondrogenesis
    Schipani, E
    SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2005, 16 (4-5) : 539 - 546
  • [9] Hypoxia and HIF-1α in osteoarthritis
    Pfander, D
    Cramer, T
    Swoboda, B
    INTERNATIONAL ORTHOPAEDICS, 2005, 29 (01) : 6 - 9
  • [10] Hypoxia and HIF-1α in osteoarthritis
    David Pfander
    Thorsten Cramer
    Bernd Swoboda
    International Orthopaedics, 2005, 29 : 6 - 9